FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063977213> ?p ?o ?g. }

• W2063977213 endingPage "89" @default.
• W2063977213 startingPage "81" @default.
• W2063977213 abstract "Background/Aims In human hepatocellular carcinoma (HCC) the ras-proto-oncogene is rarely mutated. We therefore studied the possible inactivation of the putative tumor-suppressors and ras-associating proteins, NORE1A, NORE1B, and RASSF1A in HCCs by mutation or epigenetic gene silencing through promoter-CpG hypermethylation. Methods SSCP-analyses, sequencing, and methylation-specific PCR were performed in 28 fibrotic/cirrhotic livers and 40 HCCs. Results The sequence of NORE1A/B exhibited no deviations and that of the RASSF1A gene a non-silent polymorphism (∼10% of cases) and a missense mutation (one HCC). Both alterations may affect the growth-inhibiting capability of RASSF1A. Epigenetic inactivation of NORE1B was found in 62% of the HCCs and in hepatocarcinoma-cell lines due to considerable promoter-methylation of the gene. Methylation was detected also for RASSF1A in HCCs and hepatocarcinoma cell-lines. As a result, 97% of the HCCs revealed epigenetic silencing of NORE1B, RASSF1A, or both. In contrast every third fibrotic/cirrhotic liver only exhibited silencing of one or both genes. Conclusions The candidate tumor suppressor genes NORE1B and RASSF1A are epigenetically down-regulated alone in at least 62%, or in combination in 97% of the HCCs studied. This indicates a frequent and critical event in hepatocarcinogenesis, which may allow HCCs to subverse growth-control in the presence of an unaltered Ras. In human hepatocellular carcinoma (HCC) the ras-proto-oncogene is rarely mutated. We therefore studied the possible inactivation of the putative tumor-suppressors and ras-associating proteins, NORE1A, NORE1B, and RASSF1A in HCCs by mutation or epigenetic gene silencing through promoter-CpG hypermethylation. SSCP-analyses, sequencing, and methylation-specific PCR were performed in 28 fibrotic/cirrhotic livers and 40 HCCs. The sequence of NORE1A/B exhibited no deviations and that of the RASSF1A gene a non-silent polymorphism (∼10% of cases) and a missense mutation (one HCC). Both alterations may affect the growth-inhibiting capability of RASSF1A. Epigenetic inactivation of NORE1B was found in 62% of the HCCs and in hepatocarcinoma-cell lines due to considerable promoter-methylation of the gene. Methylation was detected also for RASSF1A in HCCs and hepatocarcinoma cell-lines. As a result, 97% of the HCCs revealed epigenetic silencing of NORE1B, RASSF1A, or both. In contrast every third fibrotic/cirrhotic liver only exhibited silencing of one or both genes. The candidate tumor suppressor genes NORE1B and RASSF1A are epigenetically down-regulated alone in at least 62%, or in combination in 97% of the HCCs studied. This indicates a frequent and critical event in hepatocarcinogenesis, which may allow HCCs to subverse growth-control in the presence of an unaltered Ras." @default.
• W2063977213 created "2016-06-24" @default.
• W2063977213 creator A5000391149 @default.
• W2063977213 creator A5026319974 @default.
• W2063977213 creator A5029189456 @default.
• W2063977213 creator A5032888933 @default.
• W2063977213 creator A5038160508 @default.
• W2063977213 creator A5044159056 @default.
• W2063977213 creator A5059473104 @default.
• W2063977213 creator A5062119624 @default.
• W2063977213 creator A5079301073 @default.
• W2063977213 creator A5082720581 @default.
• W2063977213 creator A5085090061 @default.
• W2063977213 date "2006-07-01" @default.
• W2063977213 modified "2023-10-18" @default.
• W2063977213 title "NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma" @default.
• W2063977213 cites W1504197144 @default.
• W2063977213 cites W1538717269 @default.
• W2063977213 cites W1964829819 @default.
• W2063977213 cites W1973318715 @default.
• W2063977213 cites W1982393817 @default.
• W2063977213 cites W1987944428 @default.
• W2063977213 cites W1989145928 @default.
• W2063977213 cites W1994465394 @default.
• W2063977213 cites W1995114552 @default.
• W2063977213 cites W2000940387 @default.
• W2063977213 cites W2034718196 @default.
• W2063977213 cites W2036243096 @default.
• W2063977213 cites W2045796964 @default.
• W2063977213 cites W2049186397 @default.
• W2063977213 cites W2056324634 @default.
• W2063977213 cites W2066118482 @default.
• W2063977213 cites W2070393186 @default.
• W2063977213 cites W2072890735 @default.
• W2063977213 cites W2074332692 @default.
• W2063977213 cites W2078459253 @default.
• W2063977213 cites W2080560721 @default.
• W2063977213 cites W2088985926 @default.
• W2063977213 cites W2103637700 @default.
• W2063977213 cites W2113459016 @default.
• W2063977213 cites W2117839670 @default.
• W2063977213 cites W2134574909 @default.
• W2063977213 cites W2136905998 @default.
• W2063977213 cites W2139122477 @default.
• W2063977213 cites W2144529731 @default.
• W2063977213 cites W2158150128 @default.
• W2063977213 cites W2165639753 @default.
• W2063977213 cites W4243625103 @default.
• W2063977213 cites W4376849674 @default.
• W2063977213 cites W1518408982 @default.
• W2063977213 doi "https://doi.org/10.1016/j.jhep.2005.12.017" @default.
• W2063977213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16516329" @default.
• W2063977213 hasPublicationYear "2006" @default.
• W2063977213 type Work @default.
• W2063977213 sameAs 2063977213 @default.
• W2063977213 citedByCount "50" @default.
• W2063977213 countsByYear W20639772132012 @default.
• W2063977213 countsByYear W20639772132013 @default.
• W2063977213 countsByYear W20639772132014 @default.
• W2063977213 countsByYear W20639772132015 @default.
• W2063977213 countsByYear W20639772132017 @default.
• W2063977213 countsByYear W20639772132018 @default.
• W2063977213 countsByYear W20639772132019 @default.
• W2063977213 countsByYear W20639772132022 @default.
• W2063977213 crossrefType "journal-article" @default.
• W2063977213 hasAuthorship W2063977213A5000391149 @default.
• W2063977213 hasAuthorship W2063977213A5026319974 @default.
• W2063977213 hasAuthorship W2063977213A5029189456 @default.
• W2063977213 hasAuthorship W2063977213A5032888933 @default.
• W2063977213 hasAuthorship W2063977213A5038160508 @default.
• W2063977213 hasAuthorship W2063977213A5044159056 @default.
• W2063977213 hasAuthorship W2063977213A5059473104 @default.
• W2063977213 hasAuthorship W2063977213A5062119624 @default.
• W2063977213 hasAuthorship W2063977213A5079301073 @default.
• W2063977213 hasAuthorship W2063977213A5082720581 @default.
• W2063977213 hasAuthorship W2063977213A5085090061 @default.
• W2063977213 hasConcept C104317684 @default.
• W2063977213 hasConcept C119056186 @default.
• W2063977213 hasConcept C140173407 @default.
• W2063977213 hasConcept C150194340 @default.
• W2063977213 hasConcept C153911025 @default.
• W2063977213 hasConcept C190727270 @default.
• W2063977213 hasConcept C2778019345 @default.
• W2063977213 hasConcept C2778264664 @default.
• W2063977213 hasConcept C2779314089 @default.
• W2063977213 hasConcept C2781018059 @default.
• W2063977213 hasConcept C29537977 @default.
• W2063977213 hasConcept C33288867 @default.
• W2063977213 hasConcept C41091548 @default.
• W2063977213 hasConcept C502942594 @default.
• W2063977213 hasConcept C54355233 @default.
• W2063977213 hasConcept C555283112 @default.
• W2063977213 hasConcept C86803240 @default.
• W2063977213 hasConceptScore W2063977213C104317684 @default.
• W2063977213 hasConceptScore W2063977213C119056186 @default.
• W2063977213 hasConceptScore W2063977213C140173407 @default.
• W2063977213 hasConceptScore W2063977213C150194340 @default.
• W2063977213 hasConceptScore W2063977213C153911025 @default.

• next